Please use this identifier to cite or link to this item:
https://essuir.sumdu.edu.ua/handle/123456789/84480
Or use following links to share this resource in social networks:
Tweet
Recommend this item
Title | Levels of proinflammatory cytokines IL-17 and IL-23 in patients with alzheimer’s disease, mild cognitive impairment and vascular dementia |
Authors |
Dubenko, O.E.
Chyniak, Olha Serhiivna Potapov, Oleksandr Oleksandrovych |
ORCID |
http://orcid.org/0000-0002-6008-1039 http://orcid.org/0000-0002-0913-3024 |
Keywords |
Alzheimer’s disease vascular dementia interleukins |
Type | Article |
Date of Issue | 2021 |
URI | https://essuir.sumdu.edu.ua/handle/123456789/84480 |
Publisher | Aluna Publishing |
License | Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International |
Citation | Dubenko OE, Chyniak OS, Potapov OO. Levels of proinflammatory cytokines IL-17 and IL-23 in patients with alzheimer’s disease, mild cognitive impairment and vascular dementia. Wiadomosci lekarskie. 2021;74(1):68-71. doi: 10.36740/WLek202101113. |
Abstract |
To research differences of interleukin (IL)-17 and IL-23 serum levels in patients with Alzheimer’s disease, vascular dementia and mild cognitive impairment.
Material and methods: Serum levels of IL-17 and IL-23 were measure by ELISA for 15 patients with Alzheimer’s disease, 14 with vascular dementia, 30 with mild cognitive
impairment and 30 control individuals without cognitive impairment.
Results: Serum concentrations of IL-17 were significantly higher in Alzheimer’s disease patients (P=0.0023) than control, in vascular dementia no significant differences
(P=0.4154). Level of IL-23 was significantly higher than control in Alzheimer’s disease patients (P=0.0170) and vascular dementia (P=0.0002), but in Alzheimer’s disease it
was in 12.5 time higher. In total mild cognitive impairment patients no significant differences in interleukin concentration with control, but significant differences observed for
amnestic form in IL-17 (P=0.0436) and IL-23 (P=0.0019).
Conclusions: IL-17 and IL-23 level significant higher in Alzheimer’s disease patients compared with control and vascular dementia. From mild cognitive impairment levels of
detectable interleukins was higher in amnestic form that may be early marker of progression in Alzheimer’s disease. |
Appears in Collections: |
Наукові видання (НН МІ) |
Views
Belgium
19554
Chile
1
China
349318993
Egypt
1
Germany
1479
Greece
192
Hong Kong SAR China
580261697
Iran
1
Ireland
382076
Italy
1
Lithuania
1
Singapore
813435889
South Korea
183013179
Ukraine
1557771923
United Kingdom
183013177
United States
-558649078
Unknown Country
1
Vietnam
194
Downloads
Brazil
1
Chile
1
China
1
Finland
1
Germany
1
Iraq
1
Ireland
1
Lithuania
1
Ukraine
349318990
United States
-558649077
Vietnam
1
Files
File | Size | Format | Downloads |
---|---|---|---|
Dubenko_Alzheimer’s_disease.pdf | 332,17 kB | Adobe PDF | -209330078 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.